Status:
UNKNOWN
Evaluation of the Ability of CT-based Finite Element Analysis (CTFEA) to Predict Fractures in Patients With Metastases: a Randomized Controlled Study.
Lead Sponsor:
Tel-Aviv Sourasky Medical Center
Conditions:
Bone Neoplasm of Hip (Diagnosis)
Orthopedic Disorder
Eligibility:
All Genders
18-120 years
Phase:
NA
Brief Summary
Patients with metastases to proximal femur, who are evaluated fr the risk of pathologic fracture in order to decide on preventive fixation vs follow-up constitute the study population. The patients wi...
Eligibility Criteria
Inclusion
- Metastatic bone disease of femur
- Patients who undergo a CT scan (soft tissue kernel/filter, 120 kVp), and have at least 2/3 of both femurs visible in the CT scan. If CT scan is performed at the Sourasky medical center it must be according to the protocol in Appendix A.
Exclusion
- Ipsilateral previous surgery with or without implants
- Low quality CT scan or CT does not include at least 2/3 of the femurs.
- History of fractures, radiation or surgeries in lower limbs.
- Inability to provide informed consent
Key Trial Info
Start Date :
March 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2022
Estimated Enrollment :
162 Patients enrolled
Trial Details
Trial ID
NCT03453905
Start Date
March 1 2018
End Date
March 1 2022
Last Update
March 5 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.